valacyclovir + clobetasol

Valacyclovir + clobetasol is a combination therapy consisting of oral valacyclovir, an antiviral agent, and topical clobetasol, a potent corticosteroid. Valacyclovir is a prodrug that is converted in the body to acyclovir, which inhibits viral DNA synthesis by targeting herpesvirus DNA polymerase. It is primarily used to treat infections caused by herpes viruses such as herpes labialis (cold sores), genital herpes, and shingles. Clobetasol propionate acts as an agonist at the glucocorticoid receptor, suppressing inflammation through inhibition of pro-inflammatory mediators and cytokines. The combination has been shown to be more effective than monotherapy in reducing healing time for conditions like herpes labialis by both inhibiting viral replication (valacyclovir) and reducing local inflammation (clobetasol)[1][2][3][4][5][6][8].

Brand names

Valtrex